Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315811452> ?p ?o ?g. }
- W2315811452 abstract "BACKGROUND: Additional insight into the molecular alterations driving pediatric central nervous system (CNS) tumors is urgently needed, given the significant morbidity and mortality associated with these cancers and the relative paucity of effective chemotherapeutic options. Advances in sequencing technologies now allow for provision of genome-scale data to oncologists caring for pediatric cancer patients but current experience with the clinical application of genomic sequencing is limited. The goal of the BASIC3 (Baylor Advancing Sequencing into Childhood Cancer Care) study is to determine the clinical impact of incorporating CLIA-certified tumor and constitutional whole exome sequencing (WES) into the care of children with newly diagnosed solid tumors. METHODS: The study follows pediatric patients with newly diagnosed CNS and non-CNS solid tumors (target enrollment n = 280) at Texas Children's Cancer Center for two years after performing CLIA-certified whole exome sequencing (WES) of blood and frozen tumor samples. Results are deposited into the electronic medical record and disclosed to families by their oncologist and a genetic counselor. The potential impact of tumor exome findings on clinical decision-making is assessed through review of the medical record and through surveys of the oncologists regarding prioritization of treatment options in the hypothetical event of tumor recurrence. RESULTS: To date, 133 subjects have been enrolled, including 47 patients with CNS tumors (35%) comprising a diverse representation of diagnoses. Despite limited diagnostic biopsies in many patients, tumor samples adequate for WES were obtained from 33/47 (70%) patients. Tumor WES results have been reported for the first 22 CNS tumors, revealing a median of 7 (range of 0 to 25) protein-altering mutations per tumor, including alterations of known cancer genes such as ARID1A, SMARCA4, BRAF, CTNNB1, DDX3X, NF2, FANCA, and NOTCH3. Notably, 12/22 (55%) tumors were found to harbour mutations only in genes not known to be recurrently altered in human cancers. CONCLUSIONS: These results demonstrate the feasibility of routine tumor WES in the pediatric neuro- oncology clinic. Potentially clinically-relevant mutations can be identified in a substantial proportion of patients but early results suggest that integration of parallel genomic technologies (e.g. RNAseq) to identify genetic alterations not detectable by WES will be necessary; such studies are ongoing. Orthotopic xenograft models and cell lines are being established to allow in vitro and in vivo analysis of tumors containing alterations of interest. Data further assessing the clinical utility of the tumor exomes are under study. Supported by NHGRI/NCI 1U01HG006485. SECONDARY CATEGORY: Neuropathology & Tumor Biomarkers." @default.
- W2315811452 created "2016-06-24" @default.
- W2315811452 creator A5003575856 @default.
- W2315811452 creator A5006293085 @default.
- W2315811452 creator A5016664176 @default.
- W2315811452 creator A5026512721 @default.
- W2315811452 creator A5028969570 @default.
- W2315811452 creator A5032268525 @default.
- W2315811452 creator A5033462351 @default.
- W2315811452 creator A5037749785 @default.
- W2315811452 creator A5041203888 @default.
- W2315811452 creator A5045889599 @default.
- W2315811452 creator A5054728664 @default.
- W2315811452 creator A5055312193 @default.
- W2315811452 creator A5057009671 @default.
- W2315811452 creator A5059626751 @default.
- W2315811452 creator A5065618896 @default.
- W2315811452 creator A5065679041 @default.
- W2315811452 creator A5065741141 @default.
- W2315811452 creator A5068058971 @default.
- W2315811452 creator A5072079955 @default.
- W2315811452 creator A5073398031 @default.
- W2315811452 creator A5074432182 @default.
- W2315811452 creator A5077457436 @default.
- W2315811452 creator A5078484599 @default.
- W2315811452 creator A5083288793 @default.
- W2315811452 date "2014-07-01" @default.
- W2315811452 modified "2023-09-26" @default.
- W2315811452 title "ASSESSING THE UTILITY OF CLINICAL TUMOR SEQUENCING IN THE PEDIATRIC NEURO-ONCOLOGY CLINIC" @default.
- W2315811452 doi "https://doi.org/10.1093/neuonc/nou208.5" @default.
- W2315811452 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4144597" @default.
- W2315811452 hasPublicationYear "2014" @default.
- W2315811452 type Work @default.
- W2315811452 sameAs 2315811452 @default.
- W2315811452 citedByCount "0" @default.
- W2315811452 crossrefType "journal-article" @default.
- W2315811452 hasAuthorship W2315811452A5003575856 @default.
- W2315811452 hasAuthorship W2315811452A5006293085 @default.
- W2315811452 hasAuthorship W2315811452A5016664176 @default.
- W2315811452 hasAuthorship W2315811452A5026512721 @default.
- W2315811452 hasAuthorship W2315811452A5028969570 @default.
- W2315811452 hasAuthorship W2315811452A5032268525 @default.
- W2315811452 hasAuthorship W2315811452A5033462351 @default.
- W2315811452 hasAuthorship W2315811452A5037749785 @default.
- W2315811452 hasAuthorship W2315811452A5041203888 @default.
- W2315811452 hasAuthorship W2315811452A5045889599 @default.
- W2315811452 hasAuthorship W2315811452A5054728664 @default.
- W2315811452 hasAuthorship W2315811452A5055312193 @default.
- W2315811452 hasAuthorship W2315811452A5057009671 @default.
- W2315811452 hasAuthorship W2315811452A5059626751 @default.
- W2315811452 hasAuthorship W2315811452A5065618896 @default.
- W2315811452 hasAuthorship W2315811452A5065679041 @default.
- W2315811452 hasAuthorship W2315811452A5065741141 @default.
- W2315811452 hasAuthorship W2315811452A5068058971 @default.
- W2315811452 hasAuthorship W2315811452A5072079955 @default.
- W2315811452 hasAuthorship W2315811452A5073398031 @default.
- W2315811452 hasAuthorship W2315811452A5074432182 @default.
- W2315811452 hasAuthorship W2315811452A5077457436 @default.
- W2315811452 hasAuthorship W2315811452A5078484599 @default.
- W2315811452 hasAuthorship W2315811452A5083288793 @default.
- W2315811452 hasBestOaLocation W23158114521 @default.
- W2315811452 hasConcept C104317684 @default.
- W2315811452 hasConcept C10590036 @default.
- W2315811452 hasConcept C121608353 @default.
- W2315811452 hasConcept C126322002 @default.
- W2315811452 hasConcept C141231307 @default.
- W2315811452 hasConcept C142724271 @default.
- W2315811452 hasConcept C143998085 @default.
- W2315811452 hasConcept C16671776 @default.
- W2315811452 hasConcept C185592680 @default.
- W2315811452 hasConcept C2779130545 @default.
- W2315811452 hasConcept C2909143077 @default.
- W2315811452 hasConcept C2993561819 @default.
- W2315811452 hasConcept C2994067223 @default.
- W2315811452 hasConcept C501734568 @default.
- W2315811452 hasConcept C534262118 @default.
- W2315811452 hasConcept C55493867 @default.
- W2315811452 hasConcept C60644358 @default.
- W2315811452 hasConcept C71924100 @default.
- W2315811452 hasConcept C86803240 @default.
- W2315811452 hasConceptScore W2315811452C104317684 @default.
- W2315811452 hasConceptScore W2315811452C10590036 @default.
- W2315811452 hasConceptScore W2315811452C121608353 @default.
- W2315811452 hasConceptScore W2315811452C126322002 @default.
- W2315811452 hasConceptScore W2315811452C141231307 @default.
- W2315811452 hasConceptScore W2315811452C142724271 @default.
- W2315811452 hasConceptScore W2315811452C143998085 @default.
- W2315811452 hasConceptScore W2315811452C16671776 @default.
- W2315811452 hasConceptScore W2315811452C185592680 @default.
- W2315811452 hasConceptScore W2315811452C2779130545 @default.
- W2315811452 hasConceptScore W2315811452C2909143077 @default.
- W2315811452 hasConceptScore W2315811452C2993561819 @default.
- W2315811452 hasConceptScore W2315811452C2994067223 @default.
- W2315811452 hasConceptScore W2315811452C501734568 @default.
- W2315811452 hasConceptScore W2315811452C534262118 @default.
- W2315811452 hasConceptScore W2315811452C55493867 @default.
- W2315811452 hasConceptScore W2315811452C60644358 @default.
- W2315811452 hasConceptScore W2315811452C71924100 @default.
- W2315811452 hasConceptScore W2315811452C86803240 @default.
- W2315811452 hasLocation W23158114521 @default.